Abstract:Objective: To determine the target blood pressure in old people (80+ years) with frailty. Design and method: In this community based, longitudinal prospective study, we enrolled 3,134 oldest old people with frailty. The exposure-response associations between blood pressure and all-cause mortality, cardiovascular disease (CVD) mortality, and non-CVD mortality were assessed by the penalized cubic splines fitted in Cox models. Results: During 5 years follow-up, 2,532 deaths were documented. An approximate L-shaped association between systolic blood pressure (SBP) and 5-year all-cause mortality was identified. Compared with 140 mmHg (inflection point), the risk of all-cause mortality significantly increased for SBP below 127 mmHg, which varied from HR of 1.050 (95% CI: 1.003-1.100) to 1.576 (95% CI: 1.128-2.203). After 140 mmHg, mortality risk gradually fell with increasing SBP, although not reaching statistical significance. Diastolic blood pressure (DBP) suggested a significant U-shaped association with 5-year all-cause mortality with 90 mmHg conferred the lowest risk. Before that, the risk of all-cause mortality rose with decreasing DBP, which varied from HR of 1.041 (95% CI: 1.001-1.082) to 1.304 (95% CI: 1.005-1.692). After 90 mmHg, although the observed differences were not statistically significant, mortality risk tended to rise with increasing DBP. Among the 2,037 participants with a confirmed cause of death, 346 died from CVDs and 1,691 died from non-CVDs. In comparison with 120 mmHg, SBP above 134 mm Hg exhibited a significantly elevated CVD mortality risk; when SBP below 121 mmHg, significantly increased non-CVD mortality risk could be found in comparison with SBP at 140 mmHg. As for DBP, it could not predict CVD mortality risk; there was an approximate U-shaped association between DBP and non-CVD mortality that DBP below 69 mmHg was associated with a higher risk with 85 mmHg as the reference. Stratified and sensitivity analyses showed robustness of main findings. Conclusions: In the oldest old people with frailty, in addition to all-cause mortality, blood pressure management should balance CVDs risk and non-CVD risk. Maintaining blood pressure at 120-140/80-100 mmHg can reduce all-cause mortality risk and meanwhile may prevent the adverse events due to excessively higher or lower blood pressure.

Electrocardiographic Left Ventricular Hypertrophy and Mortality in an Oldest-Old Hypertensive Chinese Population.

Prevalence and Covariates of Electrocardiographic Left Ventricular Hypertrophy in the Hypertension in the Very Elderly Trial.

Electrocardiographic-left ventricular hypertrophy and incident stroke among Chinese hypertensive adults

Approach and Accuracy of Electrocardiogram in Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension

Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Combined Associations of Hs-Crp and Cognitive Function with All-Cause Mortality among Oldest-Old Adults in Chinese Longevity Areas: a Prospective Cohort Study

Value of Electrocardiographic Left Ventricular Hypertrophy As a Predictor of Poor Blood Pressure Control

GW28-e1212 Value of Electrocardiographic Left Ventricular Hypertrophy As a Predictor of Poor Blood Pressure Control: Evidence from the China Stroke Primary Prevention Trial

Prevalence and prognostic implication of left ventricular hypertrophy defined by different echocardiographic criteria

Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients

Independent Relevance of Left Ventricular Hypertrophy for Risk of Ischaemic Heart Disease in 25,000 Chinese Adults

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

The Association Between ECG Criteria and Echo Criteria for Left Ventricular Hypertrophy in a General Chinese Population

Vasculopathy Augments Cardiovascular Risk in Community-Dwelling Elderly with Left Ventricular Hypertrophy

Performance of a novel ECG criterion for improving detection of left ventricular hypertrophy: a cross-sectional study in a general Chinese population

Cardiovascular Events in Patients With Hypertension and Left Ventricular Hypertrophy: A LIFE Study

ASSOCIATION OF BLOOD PRESSURE WITH MORTALITY IN OLDEST OLD PEOPLE WITH FRAILTY IN CHINA: RESULTS FROM CHINESE LONGITUDINAL HEALTHY LONGEVITY SURVEY (CLHLS)

The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population

Study on Factors Associated with Left Ventricular Hypertrophy in the Old

Association of Left Ventricular Hypertrophy with a Faster Rate of Renal Function Decline in Elderly Patients with Non‐End‐Stage Renal Disease

Association Factors of Target Organ Damage: Analysis of 17682 Older Hypertensive Patients in China